SCHEMBL6726845

SCHEMBL6726845

[C-]#[N+]c1c(N2CCOCC2)sc(-c2nnc[nH]2)c1-c1ccc(Cl)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 9/20 0.53
MTOR P42345 3/20 0.53
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
AR P10275 1/20 0.39
CRHR1 P34998 1/20 0.37
CNR2 P34972 3/20 0.36
PIK3R1 P27986 2/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALPL P05186 1/20 0.33
MAPT P10636 1/20 0.33
MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6726829 0.97 PIK3CA (0.51) PIK3CAMTORRAB9ANPC1AR
SCHEMBL6726853 0.91 PIK3CA (0.43) PIK3CAMTORRAB9ANPC1AR
SCHEMBL6726817 0.91 PIK3CA (0.43) PIK3CAMTORRAB9ANPC1AR
SCHEMBL6726823 0.89 PIK3CA (0.42) PIK3CAMTORRAB9APIK3R1PIK3CD
SCHEMBL6726832 0.89 PIK3CA (0.42) PIK3CAMTORRAB9ANPC1AR
SCHEMBL6726826 0.87 PIK3CA (0.41) PIK3CAMTORRAB9ANPC1AR
SCHEMBL6726840 0.85 PIK3CA (0.55) PIK3CAMTORRAB9ANPC1AR
SCHEMBL6726842 0.85 PIK3CA (0.55) PIK3CAMTORRAB9ANPC1AR
SCHEMBL6726848 0.85 PIK3CA (0.39) PIK3CAMTORRAB9ANPC1PIK3CD
SCHEMBL6726847 0.85 PIK3CA (0.39) PIK3CAMTORRAB9ANPC1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130217689-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-08-22 US disclosed
US-8440664-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-05-14 US disclosed
US-20120202812-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-08-09 US disclosed
US-8183240-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-05-22 US disclosed
US-20100075951-A1 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075951-A1 Heteroaryls and uses thereof PIK3R3, AKT1S1, PIK3R1 PIK3CA 11/4885MTOR 148/4885RAB9A 2320/4885
US-20130217689-A1 HETEROARYLS AND USES THEREOF PIK3R3, AKT1S1, PIK3R1 PIK3CA 11/4885MTOR 148/4885RAB9A 2320/4885
US-20120202812-A1 HETEROARYLS AND USES THEREOF PIK3R3, AKT1S1, PIK3R1 PIK3CA 11/4885MTOR 148/4885RAB9A 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.